Influenza A virus particles strategically adapt their shape -- to become either spheres or larger filaments -- to favor their ability to infect cells depending on environmental conditions, according ...
The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...
Anthony Fauci, 84, was former President Joe Biden's chief medical adviser and a longtime director of the National Institute ...
Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline ...
The Department of Health and Human Services (HHS) canceled more than $180 million in contracts over 48 hours, including a ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
COVID-19 revealed weaknesses in our pandemic response plans and sowed distrust in science. Can we get it back?
The Department of Government Efficiency (DOGE) said on Friday that a contract worth over $168,000 for the exhibit was ...
President Donald Trump's effort to unilaterally wind down the United States Agency for International Development (USAID) has ...
In the advent of President Donald Trump’s second term, four quick, significant actions related EcoHealth Alliance, Fauci and ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback